Kreindler & Kreindler is representing victims who suffered heart attacks after taking the prescription drug Rosiglitazone, better known as Avandia.
Introduced to the market in 1999, Avandia has been widely prescribed for treatment of Type 2 Diabetes. Today, it is estimated that more than 600,000 patients in the United States take Avandia, but that is about to change. In a rare coordinated effort, regulators in the United States and Europe have announced a ban on Avandia sales in Europe, and severe restrictions on its use in the United States. In order to be prescribed Avandia in the United States, patients and doctors will be required to demonstrate that they have unsuccessfully tried all other Type 2 Diabetes medications without success. Avandia has become a drug of last resort. Even then, patients will have to be told of the substantial risks that Avandia poses to the heart.
Avandia is manufactured by British pharmaceutical giant GlaxoSmithKline. For too long, GlaxoSmithKline has tried to hide from the plain fact that its drug causes often severe heart complications and heart attacks. Only after GlaxoSmithKline was forced through litigation to make data from clinical trials of the drug available, were researchers able to learn that Avandia increased the risk of heart attack, according to some studies, by nearly 45%. It is estimated that between 45,000 and 50,000 patients have suffered heart attacks caused by Avandia.
Thousands of people injured by Avandia have successfully brought claims against GlaxoSmithKline for its failure to fully and properly test Avandia, failure to disclose the results of the tests it did conduct, and its failure to warn unsuspecting patients of the serious risks posed by the drug.
Anyone who took Avandia and suffered a heart attack within a few months of taking the drug has a strong claim for damages. Please contact us in order to learn more about Avandia and your rights. The consultation is free and without obligation. Learn your rights. Protect yourself and your family.
